After approximately one year of taking Ozempic, the plaintiff made the decision to discontinue its use in July 2023 and turned to Mounjaro for the same purpose
adults have obesity or are overweight, conditions "associated with some leading causes of death, including heart disease, stroke and diabetes, and is linked to an increased risk of certain types of cancer," the FDA says
What isnt talked about as much, however, is that our bodies already produce GLP-1 on their own
The downside is that it cannot hold more than 30 units, so once you escalate past 1.5mg (30 units at 5mg/ml), you need a larger syringe
Treatment with 5-Amino-1MQ combined with diet transition produced dramatic whole-body adiposity and weight loss, rapidly normalising these measures to levels comparable to age-matched lean control animals an outcome that diet switch alone was unable to achieve in the same time frame